MHRA Alert – September 2024 Letters and Medicine Recalls Summary

MHRA Drug Safety Update: September 2024

The MHRA has published a summary of letters and notifications issued to healthcare professionals during September 2024 concerning medicines and medical devices. This regular update ensures all clinical staff remain informed of important safety communications and product recalls.

What You Need to Know

The September 2024 alert package includes a range of safety notifications and recall notices affecting various medications and devices. These communications are issued to protect patient safety and ensure appropriate clinical decision-making across primary and secondary care settings.

Recommended Actions

• Review the full MHRA alert for specific products and medicines relevant to your clinical setting
• Check whether any recalled or affected medications are currently in use in your organisation
• Ensure all team members are aware of any relevant safety updates or product changes
• Follow local pharmacy and medicines management protocols for handling any affected stock
• Report any adverse events or suspected issues to the Yellow Card scheme

Access the Full Alert

For complete details of all September 2024 letters, recalls, and safety notifications, visit the MHRA's official alert page.

Stay updated with First Responder for the latest medicines safety information and clinical guidance.